Tradestie Institutional Equity Comparison Engine

VTAK vs SKIN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SKIN Overall Edge

SKIN Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to The Beauty Health Company Class A Common Stock (SKIN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VTAK trades at N/M Forward P/E with -388.1% operating margin (+380.7% YoY revenue) versus SKIN at 106.4x Forward P/E and 2.4% operating margin (-2.1% YoY). In options structure, VTAK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SKIN sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SKIN
VTAK N/M vs SKIN 106.4x Fwd P/E
Growth & Margin Winner SKIN
Op Margin -388.1% vs 2.4% ยท YoY +380.7% vs -2.1%
Momentum & Technical Winner SKIN
1Y -94.3% vs +1057.7% ยท 52W Pos 1% vs 83%
Options & Structure Winner SKIN
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (100th %ile IV)
VTAK NYSE American
Catheter Precision, Inc.
Surgical & Medical Instruments & Apparatus
$0.15
-0.66% 1D
Market Cap $548,639
1M Return -24.76%
1Y Return -94.28%
Forward P/E N/M
Unified AI Score
58.1 / 100 HOLD
Tech 72.0 Fund 70.0 Flow 50.0 Mom 60.0
SKIN NASDAQ
The Beauty Health Company Class A Common Stock
Surgical & Medical Instruments & Apparatus
$15.05
-7.73% 1D
Market Cap $106.3M
1M Return +42.52%
1Y Return +1057.69%
Forward P/E 106.4x
Unified AI Score
34.1 / 100 SELL
Tech 50.0 Fund 34.0 Flow 67.0 Mom 46.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VTAK -94.28% SKIN +1057.69% Spread: +41.09 pp (SKIN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VTAK Revenue SKIN Revenue VTAK Op. Margin SKIN Op. Margin Margin Edge
FY2018 $10M N/A -498.0% N/A VTAK
FY2019 $10M $170M -801.9% 8.1% SKIN
FY2020 $0M $120M -13668.3% -14.4% SKIN
FY2021 $0M $260M -133027.3% -15.4% SKIN
FY2022 $0M $370M -192578.6% -7.1% SKIN
FY2023 $0M $400M -17674.0% -32.9% SKIN
FY2024 $0M $330M -2676.9% -20.3% SKIN
FY2025 $0M $300M -2581.6% -6.9% SKIN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VTAK (4) vs SKIN (6)
Institutional Metric VTAK SKIN Criterion Row Winner
Market Capitalization Scale $548,639 $106.3M Larger Scale SKIN
Trailing P/E Ratio Valuation N/M 106.4x Lower Multiple SKIN
Forward P/E Ratio Valuation N/M 106.4x Lower Multiple SKIN
Revenue Growth (YoY) Growth +380.7% -2.1% Higher Growth VTAK
Operating Margin (TTM) Profitability -388.1% 2.4% Higher Margin SKIN
Net Profit Margin Profitability 0.0% -6.3% Higher Margin VTAK
Return on Equity (ROE) Capital Efficiency -111.3% -30.1% Higher ROE SKIN
52-Week Range Position Momentum 1% ($0โ€“$3) 83% ($0โ€“$18) Stronger Trend SKIN
Beta / 30D Volatility Risk Regime 0.19ฮฒ ยท 76% Vol -14.22ฮฒ ยท 192% Vol Lower Realized Risk VTAK
Unified Institutional Score Composite Signal 58.1 / 100 (HOLD) 34.1 / 100 (SELL) Higher Composite VTAK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VTAK vs SKIN Buy Guide
VTAK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VTAK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SKIN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live SKIN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VTAK nor SKIN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.